SCHEMBL29664483

SCHEMBL29664483

N#Cc1cc2c(nc1N)OCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 5/20 0.41
GAA P10253 4/20 0.41
ADORA1 P30542 7/20 0.39
HSD17B10 Q99714 5/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38
KHK P50053 1/20 0.38
NPSR1 Q6W5P4 4/20 0.37
HPGD P15428 3/20 0.37
RXFP1 Q9HBX9 2/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ADORA2A P29274 5/20 0.36
ADORA2B P29275 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
LMNA P02545 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24517477 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL29664488 0.79 NPSR1 (0.37) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL24517531 0.79 NPSR1 (0.37) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL31168655 0.73 CRHBP (0.37) ALDH1A1GAAADORA1NPSR1ADORA2A
SCHEMBL29664537 0.73 HSP90AA1 (0.35) KMT2AHTT
SCHEMBL1622661 0.72 MAPT (0.43) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL24517473 0.71 KDM4E (0.40) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL29618324 0.71 KDM4E (0.40) ALDH1A1KDM4EGAAADORA1HSD17B10
SCHEMBL27883168 0.70 KDM4E (0.57) ALDH1A1KDM4EGAAHSD17B10USP2
SCHEMBL26639929 0.69 HPGD (0.39) ALDH1A1KDM4EGAAADORA1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed